what are all the glp-1 drugs Market Overview: Agonists and Obesity Market | Blog Patient education tips for GLP-1,

doi: 10.1038/s41366-023-01434-x [DOI] [PubMed] [Google Scholar] 7.Wang K Ge J Han W, et al

Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity

While liraglutide also showed cardiovascular benefit (13% reduction in the LEADER trial), semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity

These drugs are getting attention for their ability to help people lose weight, but they arent magic

Krishnan, A., Hadi, Y., Hutson, W

Other food options have proven helpful in keeping patients on track: fruit (due to its capacity to healthily satiate sweet cravings), protein shakes, and homemade soups have also seen an uptick in popularity, given their balanced nutritional content and convenience for those with reduced appetites